On July 11, the PMDA held the “PMDA-ATC Generic Drugs Review Webinar 2024 for NPRA, Malaysia”.
The theme of the webinar was generic drugs review. The PMDA staff member from Master File Management Group and the Office of Generic Drugs shared information on the Japanese regulatory system and PMDA’s experiences with 39 NPRA regulators engaging in generic drugs review etc.
The PMDA continues to provide training opportunities and contributes to capacity building of NPRA.
See attached program[134 KB]
Back
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC Generic Drugs Review Webinar 2024 for NPRA, Malaysia
Events and Symposia